Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2.

Khandelwal, Vishal; Sharma, Tarubala; Gupta, Saurabh; Singh, Shoorvir; Sharma, Manish Kumar; Parashar, Deepak; Kashyap, Vivek K

Khandelwal, Vishal; Sharma, Tarubala; Gupta, Saurabh; Singh, Shoorvir; Sharma, Manish Kumar; Parashar, Deepak; Kashyap, Vivek K.

Afiliación

Khandelwal V; Department of Biotechnology, GLA University, Mathura, Uttar Pradesh, 281406, India.
Sharma T; Department of Biotechnology, GLA University, Mathura, Uttar Pradesh, 281406, India.
Gupta S; Department of Biotechnology, GLA University, Mathura, Uttar Pradesh, 281406, India.
Singh S; Department of Biotechnology, GLA University, Mathura, Uttar Pradesh, 281406, India.
Sharma MK; Department of Microbiology, Dr. Ram Manohar Lohia Avadh University, Faizabad, Uttar Pradesh, 224001, India.
Parashar D; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. dparashar@mcw.edu.
Kashyap VK; Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, 78504, USA. vivek.kashyap@utrgv.edu.

Mol Biol Rep ; 50(3): 2663-2683, 2023 Mar.

Article en En | MEDLINE | ID: mdl-36536185

Asunto(s)

COVID-19; SARS-CoV-2; Humanos; COVID-19/terapia; Interferones; Pulmón; Trasplante de Células Madre

Palabras clave

Anti-inflammatory; Cytokines; Immunomodulatory; SARS-CoV-2; Stem cell therapy; Viral infections

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Mol Biol Rep Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google